Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model – PRNewswire
  • Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model – PRNewswire
  • Novel dual CAR T cell immunotherapy holds promise for targeting the HIV reservoir – Science Daily
    Novel dual CAR T cell immunotherapy holds promise for targeting the HIV reservoir – Science Daily
  • People With Esophageal and Stomach Cancer Can Benefit From Immunotherapy – Cancer Health Treatment News
    People With Esophageal and Stomach Cancer Can Benefit From Immunotherapy – Cancer Health Treatment News
  • Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model – PRNewswire
  • Immunotherapy offers hope for prostate cancer treatment – Medical Xpress
    Immunotherapy offers hope for prostate cancer treatment – Medical Xpress
  • Medicare Coverage for Immunotherapy – Healthline
    Medicare Coverage for Immunotherapy – Healthline
  • Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model – PRNewswire
  • Immunotherapy offers hope for prostate cancer treatment – Medical Xpress
    Immunotherapy offers hope for prostate cancer treatment – Medical Xpress
  • Leveraging Immunotherapy and Targeted Therapy for Cure in Lung Cancer – OncLive
    Leveraging Immunotherapy and Targeted Therapy for Cure in Lung Cancer – OncLive
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com